Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes.

McDonald, Timothy J.; McEneny, J.; Pearson, E. R.; Thanabalasingham, G.; Szopa, M.; Shields, Beverley; Ellard, Sian; Owen, K. R.; Malecki, M. T.; Hattersley, Andrew T.; Young, I. S.

URI

http://hdl.handle.net/11287/619198

Author

McDonald, Timothy J.

McEneny, J.

Pearson, E. R.

Thanabalasingham, G.

Szopa, M.

Shields, Beverley

Ellard, Sian

Owen, K. R.

Malecki, M. T.

Hattersley, Andrew T.

Young, I. S.

Date

2012-05-18

Journal

Clinica chimica acta; international journal of clinical chemistry

Type

Research Support, Non-U.S. Gov't

Publisher

Elsevier

DOI

10.1016/j.cca.2012.02.005

Rights

Archived with thanks to Clinica chimica acta; international journal of clinical chemistry

Metadata

Show full item record

Abstract

The young-onset diabetes seen in HNF1A-MODY is often misdiagnosed as Type 2 diabetes. Type 2 diabetes, unlike HNF1A-MODY, is associated with insulin resistance and a characteristic dyslipidaemia. We aimed to compare the lipid profiles in HNF1A-MODY, Type 2 diabetes and control subjects and to determine if lipids can be used to aid the differential diagnosis of diabetes sub-type.

Citation

Lipoprotein composition in HNF1A-MODY: differentiating between HNF1A-MODY and type 2 diabetes. 2012, 413 (9-10):927-32 Clin. Chim. Acta

Publisher URL

http://www.sciencedirect.com/science/article/pii/S0009898112000678

Note

RD&E staff can access the full-text of this article via OpenAthens. Click on the 'Additional Link' above to access the full-text and log in with NHS OpenAthens if prompted.